U.S. Tech Hardware Stock News

Lazard (LAZ) is back in focus after its latest quarterly report, which paired revenue expansion with a sharp squeeze on profitability, while insider selling by key executives over the past six months added another layer for investors to weigh. See our latest analysis for Lazard. At a share price of $52.91, Lazard has paired a 1 day share price return of 2.4% with a 7 day gain of 3.6%. Its 1 year total shareholder return of 13.5% and 5 year total shareholder return of 70.3% point to momentum...

IDT Corporation, a global fintech and communications provider, recently expanded its share repurchase program after reporting resilient results across its telecom and fintech operations, while also setting its second-quarter fiscal 2026 results release and earnings call for March 10, 2026. This combination of sustained operating discipline, margin-focused execution, and increased buybacks underscores management’s conviction in the company’s intrinsic value and cash-generation profile. We’ll...

Vaxart (VXRT) is drawing fresh attention ahead of its scheduled presentation at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026. Investors will be listening for pipeline and funding updates. See our latest analysis for Vaxart. Vaxart’s recent 34.83% 7 day share price return and 102.97% 90 day share price return point to building momentum ahead of the conference, even as the 5 year total shareholder return of 87.31% highlights longer term challenges. If...

If you are wondering whether HA Sustainable Infrastructure Capital is priced fairly today, you are not alone. This article is designed to help you weigh up what you are really paying for. The stock recently closed at US$36.85, with returns of 7.2% over 30 days, 15.8% year to date, 36.9% over 1 year and 41.9% over 3 years, while the 5 year return sits at an 11.4% decline. These figures can change how investors think about both upside potential and risk. Recent news around the broader...

MercadoLibre FY 2025 earnings snapshot MercadoLibre (MELI) has wrapped up FY 2025 with fourth quarter revenue of US$8.8b and basic EPS of US$11.03, alongside net income of US$559m, putting fresh numbers behind the recent share price of US$1,740.88. The company has seen quarterly revenue move from US$6.1b and EPS of US$12.60 in Q4 2024 to US$8.8b and EPS of US$11.03 in Q4 2025, while trailing twelve month EPS sits at US$39.39 on revenue of US$28.9b. This gives investors a basis to weigh high...

PicS N.V. completed a US$434.3 million initial public offering. The company began trading on the Nasdaq Global Select Market under the ticker NasdaqGS:PICS. This is the first new stock listing by a Brazilian company in over four years. With its IPO now complete, PicS enters the public markets at a share price of $17.76 and a recent 7 day return of 17.6%. The listing of NasdaqGS:PICS also marks a return of Brazilian issuers to international equity markets after a multi year pause in new...

VEON (VEON) has been back in focus after signing a Memorandum of Understanding with Dubai based ride hailing platform Hala, along with reaffirmed multi year investment plans for Ukraine’s Kyivstar business. See our latest analysis for VEON. The new Hala MoU and Kyivstar investment update come as VEON’s share price sits at US$55.44, with a 30 day share price return of 2.46% and a 1 year total shareholder return of 23.25%. The 3 year total shareholder return is more than triple the starting...

International General Insurance Holdings (IGIC) has put income front and center by declaring an extraordinary cash dividend of $1.15 per share, payable on April 6, 2026, to shareholders of record on March 18. See our latest analysis for International General Insurance Holdings. The extraordinary and ordinary dividends, along with the recently completed US$8.09 million buyback, come after a period where the share price has moved steadily rather than sharply. The 30 day share price return is...

Terns Pharmaceuticals (TERN) has drawn attention after recent trading, with the stock closing at US$40.92. For investors, the clinical stage focus on oncology and obesity raises questions about how current pricing reflects trial progress and cash needs. See our latest analysis for Terns Pharmaceuticals. While the share price slipped around 1% on the day to US$40.92, it remains on a strong short term run, with a 16.61% 1 month share price return and a 45.57% 3 month share price return,...

Rush Enterprises (RUSH.A) is back in focus after fourth quarter results and a fresh dividend declaration, as investors weigh solid aftermarket performance, cost control and share repurchases against softer revenue and earnings figures. See our latest analysis for Rush Enterprises. The earnings beat and dividend announcement come against a share price of US$71.65, with a 30 day share price return of 14.24% and a 90 day gain of 37.63%. The 5 year total shareholder return of 164.85% suggests...

LifeStance Health Group (LFST) capped FY 2025 with fourth quarter revenue of US$382.2 million and basic EPS of US$0.03, while trailing twelve month revenue reached about US$1.4 billion with basic EPS of US$0.03. The company has seen revenue move from US$325.5 million in Q4 FY 2024 to US$382.2 million in Q4 FY 2025, alongside a shift in quarterly basic EPS from a loss of US$0.02 to a profit of US$0.03. This places improving profitability metrics at the center of the current earnings...

Crescent Energy (CRGY) closed FY 2025 with fourth quarter revenue of US$865.0 million and a small net loss of US$8.7 million, which translated into EPS of US$0.03 loss per share, while trailing 12 month revenue stood at about US$3.6 billion with net income of US$132.9 million and EPS of US$0.51. Over recent periods, revenue has ranged from US$744.9 million to US$950.2 million a quarter, with quarterly EPS swinging between a US$0.70 loss and a US$0.61 profit, so the latest numbers land in the...

If you are wondering whether Daqo New Energy’s share price really reflects what the business is worth, you are not alone, and that is exactly what this article will unpack. The stock has recently been under pressure, with a 1.5% decline over the past week, 12.0% over the last month and 19.3% year to date. However, the 1 year return stands at 11.4%, while the 3 and 5 year returns sit at 50.9% and 72.2% declines respectively. This mix of shorter term weakness and a positive 1 year return...

If you are trying to work out whether Cactus is attractively priced or not, the stock's recent moves and current valuation metrics give you quite a bit to think about. Cactus closed at US$51.56, with returns of 9.6% year to date, a 12.3% decline over the past week and an 8.7% decline over the past month, while the 1 year return sits at 0.2% and the 5 year return at 56.2%. These mixed short term moves against a relatively stronger multi year return profile set the backdrop for investors...

Regal Rexnord recently reported fourth-quarter 2025 results that exceeded analyst expectations on both earnings per share and revenue, helped by a lower tax rate despite operational challenges. Analysts have highlighted strong data center awards and expanding high-content power management roles as potentially reshaping how investors view Regal Rexnord’s growth and earnings profile. We’ll now explore how this earnings beat and upbeat commentary on data center demand may influence Regal...

Liberty Broadband director David Wargo recently sold 25,000 shares of the company’s stock, drawing attention to insider activity at the business. This insider sale comes as Liberty Broadband faces weak financial performance signals but improved operational metrics and more constructive earnings guidance. We’ll now examine how this insider selling, alongside ongoing Neutral analyst sentiment, shapes Liberty Broadband’s broader investment narrative. The future of work is here. Discover the...

National Storage Affiliates Trust (NYSE:NSA) reported solid Q4 operational progress, including better occupancy metrics and revenue trends across most markets. The company completed the consolidation of another brand, aiming to simplify its platform and improve operational consistency. NSA continued to refine its portfolio through asset sales, new acquisitions and joint ventures, while keeping liquidity conditions supportive of these moves. For investors tracking NYSE:NSA, the recent...

Churchill Downs (CHDN) has wrapped up FY 2025 with fourth quarter revenue of US$665.9 million and basic EPS of US$0.71, alongside trailing twelve month revenue of US$2.9 billion and EPS of US$5.36. The company has seen quarterly revenue move from US$624.2 million in Q4 2024 to US$665.9 million in Q4 2025, while basic EPS shifted from US$0.99 to US$0.71 over the same period. This sets up a contrast with a trailing net margin of 13.1% versus 15.6% a year earlier, which keeps investor attention...

USA Compression Partners (NYSE:USAC) plans to add substantial new compression equipment by year end. The move comes as many energy service providers report softer equipment demand and cautious upstream spending. The partnership is targeting projects tied to cleaner fuels and growing US LNG exports. For investors watching energy infrastructure, USA Compression Partners stands out for leaning into new equipment investments while much of the sector remains cautious. The units trade around...

If you are wondering whether J&J Snack Foods is starting to look attractively priced, you are not alone. This article will help you make sense of where the stock stands today. The shares last closed at US$85.11, with returns of 0.0% over 7 days, a 9.7% decline over 30 days, a 6.0% decline year to date, and a 33.6% decline over 1 year that sits against a 36.5% decline over 3 years and a 39.4% decline over 5 years. These moves have kept J&J Snack Foods on the radar for investors looking at...

ACADIA Pharmaceuticals (ACAD) capped FY 2025 with Q4 revenue of US$284 million and basic EPS of US$1.62, while trailing 12 month revenue reached about US$1.1 billion and basic EPS came in at US$2.32 as the company reported net profit margins of 36.5% over the last year, up from 23.6% the prior year. Over the past year, ACADIA has seen earnings grow 72.7% with a 5 year average earnings growth rate of 66.5% per year, and analysts currently expect earnings to grow about 8.2% per year alongside...

Nu Holdings (NYSE:NU) has capped FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$0.18, while trailing twelve month revenue sits at US$7.0b with EPS of US$0.59, underscoring a period where earnings grew 45.5% over the past year and are forecast to grow about 26.4% per year over the next three years. Over recent periods, the company has seen revenue move from US$5.5b and EPS of US$0.41 on a trailing basis in Q4 2024 to US$7.0b and EPS of US$0.59 by Q4 2025, alongside a...

Disc Medicine (NasdaqGM:IRON) received a Complete Response Letter from the FDA for its bitopertin candidate for erythropoietic protoporphyria, shifting the drug to a traditional approval pathway. The company now plans to rely on its ongoing APOLLO Phase III trial as the core data package for future regulatory submissions. Management expects APOLLO to reach full enrollment soon, making the trial a key focus for the bitopertin program. For you as an investor, this update centers on how Disc...

Howard Hughes Holdings (NYSE:HHH) is moving to acquire Vantage as it reshapes itself into a diversified holding company beyond real estate. The pending deal comes alongside record operational performance from its master planned communities and strong condominium presales. The company is aiming to broaden its revenue and earnings sources outside its traditional property focused model. For investors watching NYSE:HHH, this shift comes after a difficult stretch for the share price, with the...